CONFLUENCE LIFE SCIENCES
CLS is a drug discovery company focusing on rational drug design to discover and develop mechanistically novel kinase inhibitors for use in both human and animal health care. CLS’s kinase inhibitors target key signal transduction enzymes involved in the regulation of cancer growth and survival, or in the modulation of chronic inflammation. Unlike many other kinase inhibitor programs, however, CLS is targeting novel binding sites (on kinase targets that have proved challenging) as well as pre... viously “un-drugged” kinases. Driving CLS success in this effort is a team of world-class experts with extensive Pharma experience in kinase inhibitor discovery and development. CLS provides this team with the opportunity to pursue strategies and targets outside Pharma’s traditional focus. In addition, scientific and business collaborations are being established to enable the success of the business. The strategy is to develop and maintain a program pipeline: discover, develop, partner, repeat.
CONFLUENCE LIFE SCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2010-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.confluencelifesciences.com
Total Employee:
11+
Status:
Active
Contact:
(314) 932-4032
Email Addresses:
[email protected]
Total Funding:
13.7 M USD
Technology used in webpage:
SPF Apple Mobile Web Clips Icon OpenResty Network Solutions DNS Mimecast Network Solutions
Current Advisors List
Current Employees Featured
Founder
Investors List
Epidarex Capital
Epidarex Capital investment in Series B - Confluence Life Sciences
St. Louis Arch Angels
St. Louis Arch Angels investment in Series B - Confluence Life Sciences
Missouri Technology Corporation
Missouri Technology Corporation investment in Series B - Confluence Life Sciences
DFJ Mercury
DFJ Mercury investment in Series B - Confluence Life Sciences
BioGenerator
BioGenerator investment in Series B - Confluence Life Sciences
Epidarex Capital
Epidarex Capital investment in Series A - Confluence Life Sciences
DFJ Mercury
DFJ Mercury investment in Series A - Confluence Life Sciences
BioGenerator
BioGenerator investment in Series A - Confluence Life Sciences
Helix Fund
Helix Fund investment in Series A - Confluence Life Sciences
DFJ Mercury
DFJ Mercury investment in Series A - Confluence Life Sciences
Official Site Inspections
http://www.confluencelifesciences.com
- Host name: vux.netsolhost.com
- IP address: 206.188.192.194
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
